BRIGHTEDGE FUND
BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. The fund is led by a board comprised of the Society’s leaders and a management team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapies and technologies. The fund relies on the expertise of the Society’s medical and science professionals to evaluate the mission value of its investments. The fund’s goal is to accelerate delivery of promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.
BRIGHTEDGE FUND
Industry:
Finance Financial Services Venture Capital
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Apache Euro Amazon Organization Schema
Similar Organizations
The BFM Fund
The BFM Fund aims to provide a direct funding path for black founders.
GroundFloor
The GroundFloor impact accelerator fund at United Way of Metropolitan Dallas.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-20 | Auron Therapeutics | BrightEdge Fund investment in Series A - Auron Therapeutics | 48 M USD |
| 2022-07-19 | Persephone Biosciences | BrightEdge Fund investment in Seed Round - Persephone Biosciences | 15 M USD |
| 2022-01-26 | CellCentric | BrightEdge Fund investment in Venture Round - CellCentric | N/A |
| 2021-12-07 | Freenome | BrightEdge Fund investment in Series D - Freenome | 300 M USD |
| 2021-11-17 | Alpheus Medical | BrightEdge Fund investment in Series A - Alpheus Medical | 16 M USD |
| 2021-09-29 | TailorMed | BrightEdge Fund investment in Venture Round - TailorMed | 5 M USD |
| 2021-08-18 | Immunitas Therapeutics | BrightEdge Fund investment in Series B - Immunitas Therapeutics | 58 M USD |
| 2021-05-18 | Interius BioTherapeutics | BrightEdge Fund investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-01-28 | Auron Therapeutics | BrightEdge Fund investment in Seed Round - Auron Therapeutics | 12.75 M USD |
| 2020-08-26 | Freenome | BrightEdge Fund investment in Series C - Freenome | 270 M USD |